BioNTech to Host First Edition of Innovation Series on Diversified Pipeline, Latest Technology Innovations
MAINZ, Germany, June 20, 2022 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or the "Company”) will host the first edition of the Company’s Innovation Series on Wednesday, June 29th, 2022. The virtual event will provide an update on BioNTech’s clinical progress across its pipeline and provide a deep-dive on scientific and technology innovation from its proprietary research engine.
Investors and the interested public are invited to join a webcast with investment analysts at 8:00 a.m. EDT (2:00 p.m. CEST). Online participation will be listen-only. To listen to the webcast, you will first need to register at the following link. You will then be able to access the slide presentation and audio of the webcast via this link and log in using the same email address you used to register. The platform will open ten minutes prior to the start of the event.
A replay of the webcast will be available shorty after the conclusion of the call and archived on the Company’s website for 30 days following the call.